Paper688281
Adriamycin therapy for advanced ovarian carcinoma recurrent after chemotherapy.
Hubbard SM and 2 others. Cancer Treat Rep, 1978. Cited by 58 papers, by iCite.
Cite this record
ConductScience Library. Adriamycin therapy for advanced ovarian carcinoma recurrent after chemotherapy. Papers, record 688281. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/688281
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma | Major topic |
| Doxorubicin | Major topic |
| Ovarian Neoplasms | Major topic |
| Adult | |
| Aged | |
| Drug Evaluation | |
| Female | |
| Humans | |
| Middle Aged | |
| Neoplasm Recurrence, Local |
Source PubMed
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 58 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 23198277 | Pegylated liposomal doxorubicin/carboplatin combination in ovarian cancer, progressing on single-agent pegylated liposomal doxorubicin. | World J Clin Oncol | 2012 | https://conductscience.org/library/papers/23198277 | PubMed |
| 11986767 | A phase I dose-finding study of a combination of pegylated liposomal doxorubicin (Doxil), carboplatin and paclitaxel in ovarian cancer. | Br J Cancer | 2002 | https://conductscience.org/library/papers/11986767 | PubMed |
| 6371015 | Developing new drugs for ovarian cancer: a challenging task in a changing reality. | J Cancer Res Clin Oncol | 1984 | https://conductscience.org/library/papers/6371015 | PubMed |
| 6172215 | Chemotherapy of ovarian cancer directed by the human tumor stem cell assay. | Cancer Chemother Pharmacol | 1981 | https://conductscience.org/library/papers/6172215 | PubMed |
| 3858013 | Identification of anthracycline analogues with enhanced cytotoxicity and lack of cross-resistance to adriamycin using a series of mammalian cell lines in vitro. | Cancer Chemother Pharmacol | 1985 | https://conductscience.org/library/papers/3858013 | PubMed |
| 3459509 | The in vitro effects and cross-resistance patterns of some novel anthracyclines. | Br J Cancer | 1986 | https://conductscience.org/library/papers/3459509 | PubMed |
| 2557300 | Phase II study of esorubicin (4'-deoxydoxorubicin) in advanced epithelial carcinoma of the ovary: a Gynecologic Oncology Group study. | Invest New Drugs | 1989 | https://conductscience.org/library/papers/2557300 | PubMed |
| 2478178 | The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer. | Br J Cancer | 1989 | https://conductscience.org/library/papers/2478178 | PubMed |
| 2295117 | A phase II study of oral idarubicin in advanced recurrent or refractory ovarian carcinoma. | Cancer Chemother Pharmacol | 1990 | https://conductscience.org/library/papers/2295117 | PubMed |
| 2272774 | Phase II study of esorubicin (4'deoxydoxorubicin) in anthracycline naive patients with ovarian cancer. | Invest New Drugs | 1990 | https://conductscience.org/library/papers/2272774 | PubMed |
| 1834291 | Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. Advanced Ovarian Cancer Trialists Group. | BMJ | 1991 | https://conductscience.org/library/papers/1834291 | PubMed |
| 1503894 | Implications of an overview of chemotherapy in advanced ovarian carcinoma. | Br J Cancer | 1992 | https://conductscience.org/library/papers/1503894 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/688281
GET https://conductscience.org/api/papers/v1/688281/authors